Randomized, open-label, phase III study comparing irinotecan plus S-1 with S-1 alone in patients with advanced esophageal squamous cell carcinoma after failure of prior platinum- or taxane-based chemotherapy: Results of an interim analysis
单位：[1]CAMS, Canc Inst & Hosp, Med Oncol, Beijing, Peoples R China[2]Henan Canc Hosp, Med Oncol, Zhangzhou, Peoples R China河南省肿瘤医院[3]Taizhou Municipal Hosp, Med Oncol, Taizhou, Peoples R China[4]Xinxiang Med Univ, Affiliated Hosp 1, Med Oncol, Xinxiang, Peoples R China[5]Tianjin Canc Hosp, Med Oncol, Tianjin, Peoples R China[6]Hunan Canc Hosp, Med Oncol, Changsha, Hunan, Peoples R China[7]Herbin Med Univ, Canc Hosp, Med Oncol, Herbin, Peoples R China[8]Shandong Canc Hosp, Dept Med Oncol, Jinan, Peoples R China[9]Jiangsu Canc Hosp, Med Oncol, Nanjing, Jiangsu, Peoples R China[10]Jilin Canc Hosp, Med Oncol, Changchun, Peoples R China[11]Shanxi Canc Hosp, Radiotherapy, Taiyuan, Peoples R China[12]Shanxi Canc Hosp, Med Oncol, Taiyuan, Peoples R China[13]Tongji Hosp, Med Oncol, Wuhan, Peoples R China肿瘤科华中科技大学同济医学院附属同济医院[14]Chifeng Municipal Hosp, Med Oncol, Chifeng, Peoples R China[15]Zhengzhou Univ, Affiliated Hosp 1, Oncol, Zhengzhou, Peoples R China
第一作者单位：[1]CAMS, Canc Inst & Hosp, Med Oncol, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Huang J.,Liu Y.,Dai S.,et al.Randomized, open-label, phase III study comparing irinotecan plus S-1 with S-1 alone in patients with advanced esophageal squamous cell carcinoma after failure of prior platinum- or taxane-based chemotherapy: Results of an interim analysis[J].ANNALS OF ONCOLOGY.2016,27:doi:10.1093/annonc/mdw435.18.
APA：
Huang, J.,Liu, Y.,Dai, S.,Lu, P.,Ba, Y....&Xu, B..(2016).Randomized, open-label, phase III study comparing irinotecan plus S-1 with S-1 alone in patients with advanced esophageal squamous cell carcinoma after failure of prior platinum- or taxane-based chemotherapy: Results of an interim analysis.ANNALS OF ONCOLOGY,27,
MLA：
Huang, J.,et al."Randomized, open-label, phase III study comparing irinotecan plus S-1 with S-1 alone in patients with advanced esophageal squamous cell carcinoma after failure of prior platinum- or taxane-based chemotherapy: Results of an interim analysis".ANNALS OF ONCOLOGY 27.(2016)
医学